Skip to main content

Craig Lewis Duvall

NIH Rank #2986
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9163585Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Biomedical Engineering

NIH Funding · FY2024

Linked Award Amount
$2.8M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#2,986
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Craig Lewis Duvall. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

NIBIB

National Institute of Biomedical Imaging and Bioengineering

$0

1 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Craig Lewis Duvall as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA264508-02R01
    Next Gen Targeted nanoparticles for Inhibiting Gli2 in Bone Metastatic Tumors
    $616.2K
    award amount
  • 1R01AR083410-01A1R01
    Carrier Free siRNA Conjugates as Disease Modifying Osteoarthritis Drugs
    $595.1K
    award amount
  • 5R01EB019409-07R01
    Bioresorbable Polythioketal Urethane Wound Dressings
    $570.2K
    award amount
  • 5R01CA260958-04R01
    In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy
    $523K
    award amount
  • 5R01AR078666-03R01
    Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
    $492.5K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Craig Lewis Duvall as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Vanderbilt University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2986
  6. 2024
    Entered Top 25% Nationally
    Ranked #2986
  7. 2025
    $5M Cumulative Funding
  8. 2025
    Entered Top 10% Nationally
    Ranked #1777
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    R01 Grant Holder
  11. 2026
    $10M Cumulative Funding